AI-Augmented Diagnostic Assessment With ENLIGHT Versus Independent Pathologist Review (ENLIGHT)
This study will evaluate whether artificial intelligence (AI) can enhance clinicians' accuracy, efficiency, and confidence in distinguishing lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) and kidney renal papillary cell carcinoma (KIRP) from kidney renal clear cell carcinoma (KIRC) using digitized pathology slides. These subtype classifications are routinely performed by pathologists but can be challenging and time-consuming, particularly in difficult cases.
During the study, participating clinicians will review lung and kidney pathology slides under three different conditions:
- Unaided Review: Diagnosis without AI assistance.
- AI as Double-Check: The clinician first makes an independent diagnosis, after which the AI-generated diagnosis (prediction only or prediction with explanation) is revealed for review.
- AI as First-Look: The AI-generated diagnosis (prediction only or prediction with explanation) is presented before the clinician begins the review.
Clinicians will be randomly assigned to different review sequences to minimize potential order effects. This study design will enable us to assess the impact of AI assistance on diagnostic accuracy, interpretation time, and clinician confidence.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
- Conductual: Unaided Review First, Then AI as Double-Check, Then AI as First-Look.
- Conductual: Unaided Review First, Then AI as First-Look, Then AI as Double-Check.
- Conductual: AI as Double-Check First, Then AI as First-Look, Then Unaided Review.
- Conductual: AI as First-Look First, Then AI as Double-Check, Then Unaided Review.
Descripción detallada
This study aims to evaluate the effect of artificial intelligence (AI) assistance on clinicians' diagnostic performance in distinguishing lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) and kidney renal papillary cell carcinoma (KIRP) from kidney renal clear cell carcinoma (KIRC) using digitized hematoxylin and eosin (H&E)-stained whole-slide images (WSIs). ENLIGHT (Explainable Neoplasm Learning In Grounded Histology Terms) will serve as the AI system under evaluation. This is a single-session, within-reader, between-case study in which each reader evaluates distinct sets of cases under all study conditions.
The study includes three diagnostic blocks: Block X, in which WSIs are reviewed without AI assistance; Block Y1, in which clinicians make an initial diagnosis before viewing the AI output as a double-check; and Block Y2, in which the AI output is displayed before clinicians begin their review as a first-look aid. Within each AI-assisted block, the prediction-only and prediction-with-explanation sub-blocks are presented in randomized order.
Each participating pathologist will review up to 400 de-identified WSIs (up to 200 lung cancer and up to 200 kidney cancer cases). Readers will be randomly assigned to one of four study arms that differ only in the order in which Blocks X, Y1, and Y2 are completed. For each reader, distinct WSIs will be randomly assigned to the diagnostic conditions so that no WSI is reviewed more than once by the same reader.
- Arm 1 (X -> Y1 -> Y2): Clinicians first complete Block X (Unaided Review), followed by Block Y1 (AI as Double-Check) and then Block Y2 (AI as First-Look).
- Arm 2 (X -> Y2 -> Y1): Clinicians first complete Block X (Unaided Review), followed by Block Y2 (AI as First-Look) and then Block Y1 (AI as Double-Check).
- Arm 3 (Y1 -> Y2 -> X): Clinicians first complete Block Y1 (AI as Double-Check), followed by Block Y2 (AI as First-Look), and then Block X (Unaided Review).
- Arm 4 (Y2 -> Y1 -> X): Clinicians first complete Block Y2 (AI as First-Look), followed by Block Y1 (AI as Double-Check), and then Block X (Unaided Review).
For each case, diagnostic accuracy, time to diagnosis, and diagnostic confidence will be recorded. No reader will review the same WSI under more than one condition, thereby eliminating within-reader recall bias. In parallel, the ENLIGHT model will independently generate diagnostic predictions for all WSIs to enable direct benchmarking of AI performance against pathologists and to evaluate the impact of different AI-assisted workflows on diagnostic performance.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02115
- Harvard Medical School,
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria for Pathology Slides (i.e., Cases):
- Hematoxylin and eosin (H&E)-stained pathology slides
- Final diagnosis confirmed through molecular testing in conjunction with expert pathology evaluation
Exclusion Criteria for Pathology Slides (i.e., Cases):
- Poor-quality or unreadable slides
- Cases used in AI training
Inclusion Criteria for Readers (i.e., Participants):
- Board-certified or board-eligible pathologists
- Willingness to complete both unaided and AI-assisted review sessions
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Diagnóstico
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Cuadruplicar
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Unaided Review First, Then AI as Double-Check, Then AI as First-Look.
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
|
Comparador activo: Unaided Review First, Then AI as First-Look, Then AI as Double-Check.
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block X (Unaided) on their assigned subset SX.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
|
Comparador activo: AI as Double-Check Review First, Then AI as First-Look, Then Unaided Review.
Readers first complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
They then complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
|
Comparador activo: AI as First-Look Review First, Then AI as Double-Check, Then Unaided Review.
Readers first complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, each of the five subsets (SX, SY1a, SY1b, SY2a, and SY2b) comprises up to 80 slides: up to 40 slides from LUAD-LUSC and up to 40 slides from KIRP-KIRC.
|
Readers first complete Block Y2 (AI as First-Look) on two separate subsets: SY2a (AI prediction-only as First-Look) and SY2b (AI prediction-with-explanation as First-Look).
Within Block Y2, the order of SY2a and SY2b is randomized.
They then complete Block Y1 (AI as Double-Check) on two separate subsets: SY1a (AI prediction-only as Double-Check) and SY1b (AI prediction-with-explanation as Double-Check).
Within Block Y1, the order of SY1a and SY1b is randomized.
Then readers complete Block X (Unaided) on their assigned subset SX.
For each reader, SX, SY1a, SY1b, SY2a, and SY2b are disjoint.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Diagnostic performance of cancers
Periodo de tiempo: Periprocedural (at the time of slide review)
|
Performance of clinicians (unaided and AI-assisted) for distinguishing LUAD- LUSC and distinguishing KIRP-KIRC, measured in accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1.
|
Periprocedural (at the time of slide review)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Tiempo para diagnóstico
Periodo de tiempo: Periprocedural (en el momento de la revisión de diapositivas)
|
Tiempo promedio (segundos por caso) requerido para finalizar un diagnóstico.
|
Periprocedural (en el momento de la revisión de diapositivas)
|
|
Variabilidad entre observador
Periodo de tiempo: Periprocedural (en el momento de la revisión de diapositivas)
|
Acuerdo entre los médicos en todas las condiciones, medidos utilizando métricas de confiabilidad entre evaluadores (por ejemplo, estadísticas de Kappa).
|
Periprocedural (en el momento de la revisión de diapositivas)
|
|
Beneficio neto después de la exposición a la IA
Periodo de tiempo: Periprocedural (en el momento de la revisión de diapositivas)
|
El cambio general en la precisión diagnóstica atribuible a la asistencia de IA.
|
Periprocedural (en el momento de la revisión de diapositivas)
|
|
Clinician confidence level
Periodo de tiempo: Periprocedural (at the time of slide review)
|
Self-reported diagnostic confidence recorded for each case.
Scale: 5 - Absolutely Certain; 4 - Mostly Certain; 3 - Unsure; 2 - Very Doubtful; 1 - Random Guess; With 5 being the highest confidence score and 1 being the lowest.
|
Periprocedural (at the time of slide review)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ENLIGHT Study
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .